Close

UPDATE: Barclays Downgrades BioMarin Pharmaceutical Inc. (BMRN) to Equalweight

Go back to UPDATE: Barclays Downgrades BioMarin Pharmaceutical Inc. (BMRN) to Equalweight
BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) Delayed: 90.07 --0 (-0%)
Previous Close $90.07    52 Week High $108.96 
Open $90.07    52 Week Low $62.12 
Day High $90.07    P/E N/A 
Day Low $90.07    EPS $-1.27 
Volume 224